Leucorreducidos

Leucorreducidos is a term used in the context of blood transfusions and hematology to describe red blood cells that have undergone a reduction in their volume. This process is typically achieved through a technique called hemolysis, where the red blood cells are exposed to a hypotonic solution, causing them to swell and then lyse, or break open. The resulting mixture is then centrifuged to separate the hemoglobin from the cellular debris.

The primary goal of leucorreducidos is to obtain a concentrated source of hemoglobin, which can be used for various therapeutic purposes. Hemoglobin is a crucial component of red blood cells, and its isolation can be beneficial in situations where red blood cell transfusions are not feasible or desired. This can include conditions such as hemolytic anemia, where the patient's own red blood cells are destroyed, or in cases where the immune system reacts against transfused red blood cells, leading to hemolytic transfusion reactions.

The process of creating leucorreducidos involves several steps. First, whole blood is collected and mixed with a hypotonic solution to induce hemolysis. The resulting mixture is then centrifuged to separate the hemoglobin from the cellular debris. The hemoglobin is then purified and concentrated, resulting in a product that can be administered intravenously.

Leucorreducidos is not a standard blood product and is typically used in specialized medical settings. Its use is regulated and requires strict quality control measures to ensure safety and efficacy. The term "leucorreducidos" is specific to certain regions and may not be universally recognized, reflecting the localized nature of blood product terminology.